No Secondary Treatment Failure during Incobotulinumtoxin—A Long-Term Treatment Demonstrated by the Drawing of Disease Severity

The aim of this study was to detect clinical hints regarding the development of secondary treatment failure (STF) in patients with focal dystonia who were exclusively treated with incobotulinumtoxin/A (incoBoNT/A). In total, 33 outpatients (26 with idiopathic cervical dystonia, 4 with Meige syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Brauns, Raphaela, Ürer, Beyza, Rosenthal, Dietmar, Albrecht, Philipp, Samadzadeh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467049/
https://www.ncbi.nlm.nih.gov/pubmed/37505723
http://dx.doi.org/10.3390/toxins15070454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467049/
https://www.ncbi.nlm.nih.gov/pubmed/37505723
http://dx.doi.org/10.3390/toxins15070454

Ejemplares similares